在阿尔茨海默病和其他形式的痴呆症中的神经免疫功能障碍
Takuya Yamane1, Takeshi Yoshioka1, Yusuke Shimo1
1Laboratory for Drug Discovery and Disease Research, Shionogi & Co., Ltd.
Chemical & pharmaceutical bulletin
|June 30, 2024
概括
阿尔茨海默病 (AD) 涉及到大脑免疫细胞功能障碍. 准神经炎症和特定的免疫细胞为阿尔茨海默病和痴呆症提供了新的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 阿尔茨海默病 (AD) 是一种常见的痴呆症,其中粉样β (Aβ) 和病理是主要的目标.
- 针对Aβ和tau的AD现有的治疗方法在临床上取得了有限的成功.
- 新出现的证据表明,在阿尔茨海默病的发病过程中,免疫系统的异常和微质细胞功能障碍.
研究的目的:
- 审查遗传证据,生物标志物和AD的病理生理学,专注于神经免疫功能障碍.
- 要突出微质在维持大脑平衡中的双重作用,以及它们对AD的贡献.
- 探索针对神经免疫通路的治疗策略,并讨论针对AD的精准医学方法.
主要方法:
- 关于AD相关的遗传研究,成像和生物流体生物标志物的文献综述.
- 在AD的背景下分析微质功能和神经炎症.
- 在AD中确定神经免疫功能障碍的候选药物和治疗点.
主要成果:
- 遗传因素和与免疫/小质相关的基因与阿尔茨海默病的发展有关.
- 微质功能障碍导致慢性神经炎症和AD中神经免疫反应受损.
- 神经免疫功能障碍是关键因素连接到AD的发病.
结论:
- 针对神经免疫功能障碍,为阿尔茨海默病提供了一个有前途的治疗途径.
- 精准医学方法分析遗传风险因素和免疫细胞种群对于未来的AD治疗至关重要.
- 调节微质功能和神经炎症可能为AD提供新的治疗策略.
相关概念视频
Alzheimer's Disease: Overview
461
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
461
Disorders of the Nervous Tissue
1.1K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.1K
Alzheimer's Disease: Treatment
178
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
178
Dementia
110
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
110
Neural Regulation
39.3K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.3K
Role of Neurotransmitters in Memory
519
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
519


